Abstract
Background
Breast cancer is one of the most common causes of death for women worldwide. While chemotherapy is the treatment option for most cancers, surgery, chemotherapy, and radiotherapy are the three main therapeutic strategies for the treatment of breast cancer. In recent years, nanotechnology applications for cancer treatments have attracted a lot of attention.
Area covered
This review focuses on the various nanoparticle types, such as liposomes, micelles, polymeric nanoparticles, solid lipid nanoparticles, and gold nanoparticles, and their applications for the treatment of breast cancer.
Expert opinion
In recent decades, nanotechnology has developed and been applied to cancer treatments. Currently, nanotechnology plays an important role in the targeted delivery of drugs for cancer treatments, including breast cancer. Nanoparticles can target tumors and control the release of drugs to precise sites, thereby improving the therapeutic efficiency of drugs and decreasing the toxicity to normal tissues or organs. In addition, nanoparticles are also able to activate immune cells against tumors. Therefore, nanoparticles are a promising tool for future cancer research and treatment.
Similar content being viewed by others
References
American Cancer Society I (2018) Cancer facts & figures 2018. Atlanta: American Cancer Society. BMJ 309:1689. https://doi.org/10.1136/bmj.309.6970.1689
Anders CK, Adamo B, Karginova O et al (2013) Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer. PLoS ONE 8:e61359. https://doi.org/10.1371/journal.pone.0061359
Arvizo R, Bhattacharya R, Mukherjee P (2010) Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv 7:753–763. https://doi.org/10.1517/17425241003777010
Bangham AD, Horne RW (1964) Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660. https://doi.org/10.1016/s0022-2836(64)80115-7
Batrakova EV, Li S, Elmquist WF et al (2001) Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletion. Br J Cancer 85:1987–1997. https://doi.org/10.1054/bjoc.2001.2165
Bi X, Yuan Q, Han J et al (2014) Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. Int J Nanomed. https://doi.org/10.2147/IJN.S70919
Carty NJ, Foggitt A, Hamilton CR et al (1995) Patterns of clinical metastasis in breast cancer: an analysis of 100 patients. Eur J Surg Oncol 21:607–608
Cho CW, Baek JS, Kim JH, Park JS (2015) Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-beta-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection. Int J Nanomed. https://doi.org/10.2147/IJN.S86474
Choi JS, Park JS (2017) Surface modification of docetaxel nanocrystals with HER2 antibody to enhance cell growth inhibition in breast cancer cells. Colloids Surf B Biointerfaces 159:139–150. https://doi.org/10.1016/j.colsurfb.2017.07.064
Choi JS, Jang WS, Park JS (2018a) Comparison of adsorption and conjugation of Herceptin on poly(lactic-co-glycolic acid) nanoparticles—effect on cell internalization in breast cancer cells. Mater Sci Eng C 92:496–507. https://doi.org/10.1016/j.msec.2018.06.059
Choi J, Lee SE, Park JS, Kim SY (2018b) Gold nanorod-photosensitizer conjugates with glutathione-sensitive linkages for synergistic cancer photodynamic/photothermal therapy. Biotechnol Bioeng 115:1340–1354. https://doi.org/10.1002/bit.26536
Chu B, Shi S, Li X et al (2016) Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy. Int J Pharm 513:118–129. https://doi.org/10.1016/j.ijpharm.2016.09.005
Colleoni M, Rocca A, Sandri MT et al (2002) Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 13:73–80. https://doi.org/10.1093/annonc/mdf013
Du M, Ouyang Y, Meng F et al (2019) Polymer-lipid hybrid nanoparticles: a novel drug delivery system for enhancing the activity of psoralen against breast cancer. Int J Pharm 561:274–282. https://doi.org/10.1016/j.ijpharm.2019.03.006
Eloy JO, Petrilli R, Topan JF et al (2016) Co-loaded paclitaxel/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids Surf B Biointerfaces 141:74–82. https://doi.org/10.1016/j.colsurfb.2016.01.032
Esfahani MKM, Alavi SE, Movahedi F et al (2013) Cytotoxicity of liposomal paclitaxel in breast cancer cell line MCF-7. Indian J Clin Biochem 28:358–360. https://doi.org/10.1007/s12291-013-0296-1
Franco MS, Roque MC, de Barros ALB et al (2019) Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model. Biomed Pharmacother 109:1728–1739. https://doi.org/10.1016/j.biopha.2018.11.011
François A, Laroche A, Pinaud N et al (2011) Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer Cells. ChemMedChem 6:2003–2008. https://doi.org/10.1002/cmdc.201100311
Gabizon AA, Patil Y, La-Beck NM (2016) New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy. Drug Resist Updat 29:90–106. https://doi.org/10.1016/j.drup.2016.10.003
García Calavia P, Chambrier I, Cook MJ et al (2018) Targeted photodynamic therapy of breast cancer cells using lactose-phthalocyanine functionalized gold nanoparticles. J Colloid Interface Sci 512:249–259. https://doi.org/10.1016/j.jcis.2017.10.030
Gradishar WJ (2012) Taxanes for the treatment of metastatic breast cancer. Breast Cancer Basic Clin Res 6:BCBCR.S8205. https://doi.org/10.4137/bcbcr.s8205
Grobmyer SR, Zhou G, Gutwein LG et al (2012) Nanoparticle delivery for metastatic breast cancer. Nanomed Nanotechnol Biol Med 8:S21–S30. https://doi.org/10.1016/j.nano.2012.05.011
Güney G, Kutlu HM (2011) Importance of solid lipid nanoparticles in cancer therapy. Nanotechnology 2011(3):400–403
Guney Eskiler G, Cecener G, Dikmen G et al (2018) Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer. Eur J Pharm Sci 120:73–88. https://doi.org/10.1016/j.ejps.2018.04.040
Jadon RS, Sharma M (2019) Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics. J Drug Deliv Sci Technol 51:475–484. https://doi.org/10.1016/j.jddst.2019.03.039
Jain AK, Das M, Swarnakar NK, Jain S (2011) Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst 28:1–45
Jeong UH, Garripelli VK, Jo S et al (2014) Potential of pH-sensitive polymer-anchored cationic liposomes for combinatorial anticancer therapy with doxorubicin and siRNA. J Drug Deliv Sci Technol 24:27–32. https://doi.org/10.1016/S1773-2247(14)50004-4
Jordan VC (2014) Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer. Endocr Relat Cancer 21:R235–R246. https://doi.org/10.1530/ERC-14-0092
Joshi P, Chakraborti S, Ramirez-Vick JE et al (2012) The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells. Colloids Surf B Biointerfaces 95:195–200. https://doi.org/10.1016/j.colsurfb.2012.02.039
Joshi MD, Patravale V, Prabhu R (2015) Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomed. https://doi.org/10.2147/IJN.S56932
Kang DI, Kang H-K, Gwak H-S et al (2009) Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Drug Deliv 16:261–267. https://doi.org/10.1080/10717540902937562
Kang KW, Chun M-K, Kim O et al (2010) Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy. Nanomed Nanotechnol Biol Med 6:210–213. https://doi.org/10.1016/j.nano.2009.12.006
Kutty RV, Feng S-S (2013) Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials 34:10160–10171. https://doi.org/10.1016/j.biomaterials.2013.09.043
Lee S, Chon H, Lee M et al (2009) Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres. Biosens Bioelectron 24:2260–2263. https://doi.org/10.1016/j.bios.2008.10.018
Lee SE, Lee CD, Bin Ahn J et al (2019) Hyaluronic acid-coated solid lipid nanoparticles to overcome drug-resistance in tumor cells. J Drug Deliv Sci Technol 50:365–371. https://doi.org/10.1016/j.jddst.2019.01.042
Licciardi M, Li Volsi A, Mauro N et al (2016) Preparation and characterization of inulin coated gold nanoparticles for selective delivery of doxorubicin to breast cancer cells. J Nanomater 2016:1–12. https://doi.org/10.1155/2016/2078315
Lim Z-ZJ, Li J-EJ, Ng C-T et al (2011) Gold nanoparticles in cancer therapy. Acta Pharmacol Sin 32:983–990. https://doi.org/10.1038/aps.2011.82
Lu L, Garcia CA, Mikos AG (1999) In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films. J Biomed Mater Res 46:236–244
Lu L, Peter SJ, Lyman MD et al (2000) In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams. Biomaterials 21:1837–1845
Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–1397. https://doi.org/10.3390/polym3031377
Manju S, Sreenivasan K (2010) Functionalised nanoparticles for targeted drug delivery. In: Sharma C (ed) Biointegration of medical implant materials. Elsevier, pp 267–297
Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–196
Mishra P, Dey RK (2018) Co-delivery of docetaxel and doxorubicin using biodegradable PEG-PLA micelles for treatment of breast cancer with synergistic anti-tumour effects. J Macromol Sci Part A 55:310–316. https://doi.org/10.1080/10601325.2018.1426390
Nguyen KT (2011) Targeted nanoparticles for cancer therapy: promises and challenges. J Nanomed Nanotechnol. https://doi.org/10.4172/2157-7439.1000103e
Park TG (1995) Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 16:1123–1130. https://doi.org/10.1016/0142-9612(95)93575-X
Patt D, Gauthier M, Giordano S (2006) Paclitaxel in breast cancer. Women’s Heal 2:11–21. https://doi.org/10.2217/17455057.2.1.11
Qureshi OS, Kim H-S, Zeb A et al (2017) Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration. J Microencapsul 34:250–261. https://doi.org/10.1080/02652048.2017.1337247
Raju A, Muthu MS, Feng S-S (2013) Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opin Drug Deliv 10:747–760. https://doi.org/10.1517/17425247.2013.777425
Rong L, Zhou S, Liu X et al (2017) Trastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: an in vitro and in vivo study. Artif Cells Nanomed Biotechnol. https://doi.org/10.1080/21691401.2017.1391821
Rosch JG, Winter H, DuRoss AN et al (2019) Inverse-micelle synthesis of doxorubicin-loaded alginate/chitosan nanoparticles and in vitro assessment of breast cancer cytotoxicity. Colloid Interface Sci Commun 28:69–74. https://doi.org/10.1016/j.colcom.2018.12.002
Sabra SA, Sheweita SA, Haroun M et al (2019) Magnetically guided self-assembled protein micelles for enhanced delivery of dasatinib to human triple-negative breast cancer cells. J Pharm Sci 108:1713–1725. https://doi.org/10.1016/j.xphs.2018.11.044
Shenoy DB, Amiji MM (2005) Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293:261–270. https://doi.org/10.1016/j.ijpharm.2004.12.010
Shewach DS, Kuchta RD (2009) Introduction to cancer chemotherapeutics. Chem Rev 109:2859–2861. https://doi.org/10.1021/cr900208x
Singh S, Singh S, Lillard JW Jr, Singh R (2017) Drug delivery approaches for breast cancer. Int J Nanomed 12:6205–6218. https://doi.org/10.2147/IJN.S140325
Sohn JS, Yoon D-S, Sohn JY et al (2017) Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals. Mater Sci Eng C 72:228–237. https://doi.org/10.1016/j.msec.2016.11.065
Subedi RK, Kang KW, Choi H-K (2009) Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 37:508–513. https://doi.org/10.1016/j.ejps.2009.04.008
Teixeira RAR, Lataliza AAB, Raposo NRB et al (2018) Insights on the transport of tamoxifen by gold nanoparticles for MCF-7 breast cancer cells based on SERS spectroscopy. Colloids Surf B Biointerfaces 170:712–717. https://doi.org/10.1016/j.colsurfb.2018.07.001
U.S. Food and Drug Administration (1995) Doxil. In: Sarcoma. http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050718s029lbl.pdf. Accessed 2 May 2019
Wan X, Beaudoin JJ, Vinod N et al (2019) Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials 192:1–14. https://doi.org/10.1016/j.biomaterials.2018.10.032
Wong M-Y, Chiu GNC (2010) Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. Anticancer Drugs 21:401–410. https://doi.org/10.1097/CAD.0b013e328336e940
World Health Organization (2014) World cancer factsheet. Cancer Res. https://www.cancerresearchuk.org/sites/default/files/cs_report_world.pdf. Accessed 15 Jan 2019
Xu W, Bae EJ, Lee M-K (2018) Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells. Int J Nanomed 13:7549–7563. https://doi.org/10.2147/IJN.S182621
Zhang Y, Huang Y, Li S (2014) Polymeric micelles: nanocarriers for cancer-targeted drug delivery. AAPS PharmSciTech 15:862–871. https://doi.org/10.1208/s12249-014-0113-z
Zhang T, Luo J, Fu Y et al (2017) Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer. Colloids Surf B Biointerfaces 150:89–97. https://doi.org/10.1016/j.colsurfb.2016.11.024
Zhou Z, Kennell C, Jafari M et al (2017) Sequential delivery of erlotinib and doxorubicin for enhanced triple negative breast cancer treatment using polymeric nanoparticle. Int J Pharm 530:300–307. https://doi.org/10.1016/j.ijpharm.2017.07.085
Zhuang Y-G, Xu B, Huang F et al (2012) Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model. Pharmazie 67:925–929
Acknowledgements
This work was supported by research fund of Chungnam National University in 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Research involving human and animal rights
This review does not contain any studies with human and animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tran, P., Lee, SE., Kim, DH. et al. Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment. J. Pharm. Investig. 50, 261–270 (2020). https://doi.org/10.1007/s40005-019-00459-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-019-00459-7